Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests

For people with diabetes treated with insulin, Dexcom rtCGM is associated with significant improvements over patients’ lifetimes and is likely to be cost-saving to the NHS

... | May 3, 2023

Related Keywords

San Diego ,California ,United States ,France ,United Kingdom ,Ben Byrne ,National Health Service ,Dexcom Inc ,Association Of Continuous Glucose Monitoring With Glycemic ,Nasdaq ,Blood Glucose ,Insulin Therapy ,Dexcom Clarity ,Dexcom Follow ,Dexcom One ,Dexcom Share ,Patients With Type ,Dexcom ,Nc Stock Exchange ,News ,Information ,Press Release ,Or ,People ,Ith ,Diabetes ,Reated ,Nexcom ,Rtcgm ,Us ,Ssociated ,Significant ,Improvements ,Dover ,Lifetimes ,End ,Likely ,O ,The ,He Dxcm Us2521311074 ,